Finke, Juergen; Schmoor, Claudia; Ayuk, Francis et al.
Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)BONE MARROW TRANSPLANTATION. 2024
Finke, Juergen; Schmoor, Claudia; Ayuk, Francis et al.
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study) (MAR, 10.1038/s41409-024-02264-9, 2024)BONE MARROW TRANSPLANTATION. 2024
Matasar, Matthew; Bartlett, Nancy L.; Shadman, Mazyar et al.
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II TrialCLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Bd. 24. H. 4. 2024 S. 240-253
Schoepf, Julia; Uhrig, Sebastian; Heilig, Christoph E. et al.
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusionsNATURE COMMUNICATIONS. Bd. 15. H. 1. 2024
Lin, Chun-Pu; Levy, Pierre L.; Alflen, Astrid et al.
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitnessCANCER CELL. Bd. 42. H. 4. 2024
De Waele, Laure; Sakai, Kazuya; Mancini, Ilaria et al.
Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpuraJOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 22. H. 2. 2024 S. 493-502
Singer, Susanne; Bayer, Oliver; Schranz, Melanie et al.
Patient-reported outcomes in medical registries. Experiences from an application-accompanying data collectionONKOLOGIE. 2024
Kansy, Anita G.; Ashry, Ramy; Mustafa, Al-Hassan M. et al.
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cellsMOLECULAR ONCOLOGY. 2024
Brandt, Anna; Schultheiss, Christoph; Klinghammer, Konrad et al.
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trialFRONTIERS IN ONCOLOGY. Bd. 14. 2024
Ayuk, Francis; Wagner-Drouet, Eva-Maria; Wolff, Daniel et al.
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA studyBONE MARROW TRANSPLANTATION. 2024